dulaglutide vs semaglutide vs tirzepatide Efficacy of versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial | Diabetologia Tirzepatide vs. Semaglutide: Key Differences

This pharmacological profile makes it uniquely well-suited as the GHS-R1a component of a dual-receptor combination, adding acute calcium-dependent GH vesicle release without the adrenal or gonadal axis interference that complicates use of other GHRPs

Their ability to interpret complex laboratory results and order specialized testing provides thorough evaluation

Human kidneys contain around 1 million nephrons

The obesity indication timeline remains less certain

The peptide is constructed on a GIP receptor backbone with non-coded amino acid residues (Aib2, Aib20, aMeL13) and a C20 fatty diacid moiety that enables albumin binding, extending pharmacokinetic half-life for once-weekly administration in research settings